Insight Molecular DiagnosticIMDX

13F holders, Q1 2026 (March 31)
41holders +6
14new positions
7sold out
2famous investors
$3.28avg. 13F price*

At the end of Q1 2026, 41 institutions reported holding Insight Molecular Diagnostic (IMDX) in their 13F filings, up 6 from Q4 2025. 14 opened new positions and 7 sold out. The largest holders were Broadwood Capital Inc. ($39.1M), AWM Investment Company, Inc. ($9.2M) and Pura Vida Investments, LLC ($3.1M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).

Company
Insight Molecular Diagnostic
CUSIP
68235C206
Latest filing quarter
Q2 2026

History

Number of 13F holders

01020304050 Q1 2024: 23Q1 2024Q2 2024: 21Q2 2024Q3 2024: 20Q3 2024Q4 2024: 26Q4 2024Q1 2025: 29Q1 2025Q2 2025: 30Q2 2025Q3 2025: 27Q3 2025Q4 2025: 35Q4 2025Q1 2026: 41Q1 2026Q2 2026: 40Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions14$4.9M
Exits7$818K

All 13F filers, Q4 2025 → Q1 2026: 2,338,546 shares bought and 200,449 shares sold, net +2,138,097 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 41 holders

Broadwood Capital Inc. 2.76% Add +4.6% 11,931,839 $39.1M
AWM Investment Company, Inc. 1.02% Reduce -0.3% 2,806,256 $9.2M
Pura Vida Investments, LLC 20.88% No change 947,134 $3.1M
Alyeska Investment Group, L.P. 0.01% New 840,777 $2.8M
Vanguard Capital Management LLC 0.00% — 537,161 $1.8M
Heights Capital Management, Inc. 0.36% New 392,545 $1.3M
Geode Capital Management, LLC 0.00% Add +13.5% 262,053 $860K
FNY Investment Advisers, LLC 0.36% Add +509.6% 247,421 $811K
BlackRock, Inc. 0.00% Add +3.0% 135,345 $444K
Vanguard Fiduciary Trust Co. 0.00% — 132,591 $435K
Family Office Research LLC 0.18% New 127,266 $417K
Millennium Management 0.00% Add +68.6% 103,470 $339K
Ghisallo Capital Management LLC 0.01% New 70,695 $232K
Susquehanna International Group, LLP 0.00% Reduce -22.6% 56,093 $184K
State Street Corp. 0.00% Add +6.3% 50,754 $166K
Northern Trust Corp. 0.00% Add +0.5% 49,090 $161K
Morgan Stanley 0.00% Add +0.5% 36,088 $118K
XTX Topco Ltd 0.00% New 30,353 $100K
683 Capital Management, LLC 0.01% Reduce -62.4% 29,000 $95K
Qube Research & Technologies Ltd 0.00% Reduce -11.0% 25,230 $83K
Osaic Holdings, Inc. 0.00% Reduce 0.0% 24,135 $79K
UBS Group AG 0.00% Add +673.6% 22,751 $75K
Engineers Gate Manager LP 0.00% New 18,253 $60K
Flatrock Wealth Partners LLC 0.02% New 13,044 $43K
Point72 Asset Management 0.00% New 12,250 $40K
OMERS ADMINISTRATION Corp 0.00% Reduce -59.9% 10,500 $34K
Private Advisor Group, LLC 0.00% No change 10,416 $34K
Vanguard Global Advisers, LLC 0.00% — 5,775 $19K
EverSource Wealth Advisors, LLC 0.00% No change 5,000 $16K
Advisory Services Network, LLC 0.00% New 3,100 $10K
Citigroup Inc. 0.00% Add +81400.0% 815 $3K
Ascentis Independent Advisors 0.00% New 450 $1K
SBI Securities Co., Ltd. 0.00% No change 185 $607
JPMorgan Chase & Co. 0.00% No change 154 $393
BNP Paribas Financial Markets 0.00% Add +113.3% 64 $210
Piscataqua Savings Bank 0.00% No change 25 $81
Cassaday & Co Wealth Management LLC 0.00% New 10 $33
Albion Financial Group 0.00% No change 7 $23
Caitong International Asset Management Co., Ltd 0.00% New 1 $3
Farther Finance Advisors, LLC 0.00% New 1 $3
Federation des caisses Desjardins du Quebec 0.00% New 1 $3

"% of holder's portfolio" is IMDX's weight in each manager's 13F, not the share of Insight Molecular Diagnostic the manager owns.